Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lipase
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lipase is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Exocrine Pancreatic Insufficiency.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
July 20, 2022
Lead Product(s) : Lipase
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable